GRI.NASDAQGri Bio, INC

SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in GRI Bio

Sentiment:

Beneficial Ownership Disclosure

📋All filings for Gri Bio, INC
🔒Login to Follow

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 9.99% beneficial ownership stake in GRI Bio, Inc. following a recent Securities Purchase Agreement.

Capital raiseThe filing references a Securities Purchase Agreement (SPA) executed on December 11, 2025, which involved the issuance of common stock and warrants to Intracoastal Capital LLC.360,000 shares of Common Stock were to be issued to Intracoastal at the closing of the transaction contemplated by the SPA.2,603,331 shares of Common Stock were issued in aggregate at the closing of the transaction contemplated by the SPA.550,000 shares of Common Stock were issued to Intracoastal upon exercise of Intracoastal Warrant 1.Multiple warrants (Intracoastal Warrant 1, 2, 3, 4, 5) were issued or are issuable, allowing for future equity conversion, indicating a capital raise mechanism.

Summary

  • Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC collectively reported beneficial ownership of 677,477 shares of GRI Bio, Inc. common stock.
  • This represents approximately 9.99% of the company's common stock as of December 17, 2025.
  • The ownership includes 317,981 shares directly held by Intracoastal and 359,496 shares issuable upon exercise of Intracoastal Warrant 1.
  • The reporting persons' beneficial ownership is capped at 9.99% due to blocker provisions in various warrants, which prevent exercise beyond this threshold.
  • Without these blocker provisions, the reporting persons would have been deemed to beneficially own 4,766,318 shares of Common Stock as of December 17, 2025.
  • The initial beneficial ownership immediately following the Securities Purchase Agreement on December 11, 2025, was 362,788 shares, also representing 9.99%.
  • The shares were not acquired for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing indicates a significant investment by an institutional entity, which is generally a positive signal for the company. The capital raise provides funding. However, it's a factual disclosure of ownership, not a performance report, so the sentiment is moderately positive rather than strongly positive.

Positives

  • The company has successfully attracted a significant investment from Intracoastal Capital LLC, demonstrating investor confidence.
  • The Securities Purchase Agreement provides capital to GRI Bio, Inc., which can support its operations and strategic initiatives.

Negatives

  • The filing itself does not present explicit negatives regarding GRI Bio, Inc.'s operational or financial performance.

Risks

  • The issuance of warrants, even with blocker provisions, represents potential future dilution for existing shareholders if and when these warrants are fully exercised.
  • A significant concentration of ownership, even if passive, could influence market perception or liquidity.

Stakeholder Impact

  • Shareholders: Potential for increased investor confidence due to a significant institutional stake. Potential for dilution from warrant exercises, though this is managed by blocker provisions.
  • Company: Receipt of capital from the Securities Purchase Agreement.

Key Dates

DateDescription
2025-12-01Date as of which 3,268,727 shares of Common Stock were outstanding, as reported by the Issuer.
2025-12-11Date of event which requires filing of this statement; execution of the Securities Purchase Agreement (SPA) with the Issuer.
2025-12-12Date Form 8-K was filed by the Issuer disclosing the SPA.
2025-12-17Date as of which beneficial ownership of 677,477 shares was reported by each Reporting Person.

Keywords

GRI Bio Inc, Common Stock, Schedule 13G, Beneficial Ownership, Intracoastal Capital, Mitchell P. Kopin, Daniel B. Asher, SEC Filing, Investment, Warrants, Blocker Provisions, Capital Raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.